Roivant Sciences (ROIV) Earnings Date, Estimates & Call Transcripts → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ROIV Stock Alerts $10.88 -0.02 (-0.18%) (As of 04/25/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateJun. 26EstimatedActual EPS (Feb. 13) -$0.26 Beat By $0.07 Consensus EPS (Feb. 13) -$0.33 Get Roivant Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for ROIV and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueROIV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ROIV Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Roivant Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.33)($0.33)($0.33)Q2 20241($0.33)($0.33)($0.33)Q3 20241($0.33)($0.33)($0.33)Q4 20243($0.39)($0.20)($0.31)FY 20246($1.38)($1.19)($1.30)Q1 20252($0.25)($0.21)($0.23)Q2 20252($0.39)($0.22)($0.31)Q3 20252($0.41)($0.22)($0.32)Q4 20252($0.44)($0.22)($0.33)FY 20258($1.49)($0.87)($1.18)ROIV Earnings Date and InformationRoivant Sciences last posted its earnings results on February 13th, 2024. The reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.07. The business earned $37.14 million during the quarter, compared to analysts' expectations of $30.72 million. Roivant Sciences has generated $5.20 earnings per share over the last year ($5.20 diluted earnings per share) and currently has a price-to-earnings ratio of 2.1. Earnings for Roivant Sciences are expected to grow in the coming year, from ($1.36) to ($1.35) per share. Roivant Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 26th, 2024 based off prior year's report dates.Read More Roivant Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/26/2024Estimated)------- 2/13/2024Q3 2024($0.33)($0.26)+$0.07($6.55)$30.72 million$37.14 million11/13/2023Q2 2024($0.35)($0.33)+$0.02($0.26)$26.68 million$37.10 million8/14/2023Q2 2023($0.28)($0.38)($0.10)($0.38)$24.49 million$21.60 million 6/28/2023Q4 2023($0.41)($0.20)+$0.21($0.35)$18.94 million$27.38 million2/13/2023Q3 2023($0.36)($0.49)($0.13)($0.49)$14.29 million$17.05 million11/14/2022Q2 2023($0.41)($0.42)($0.01)($0.42)$6.71 million$12.53 million Get the Latest News and Ratings for ROIV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/15/2022Q1 2023($0.30)($0.48)($0.18)($0.48)$6.45 million$4.32 million6/28/2022Q4 2022($0.25)($0.39)($0.14)($0.39)$11.94 million$9.22 million2/14/2022Q3 2022($0.23)($0.41)($0.18)($0.41)$10.13 million$24.34 million 11/15/2021Q2 2022($1.06)($0.87)+$0.19($1.42)$5.30 million$13.99 million9/21/2021Q1 2022-($0.37)($0.37)($0.37)-$7.74 million Roivant Sciences Earnings - Frequently Asked Questions When is Roivant Sciences's earnings date? Roivant Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 26th, 2024 based off last year's report dates. Learn more on ROIV's earnings history. Did Roivant Sciences beat their earnings estimates last quarter? In the previous quarter, Roivant Sciences (NASDAQ:ROIV) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.33) by $0.07. Learn more on analysts' earnings estimate vs. ROIV's actual earnings. How much revenue does Roivant Sciences generate each year? Roivant Sciences (NASDAQ:ROIV) has a recorded annual revenue of $61.28 million. How much profit does Roivant Sciences generate each year? Roivant Sciences (NASDAQ:ROIV) has a recorded net income of -$1.01 billion. ROIV has generated $5.20 earnings per share over the last four quarters. What is Roivant Sciences's price-to-earnings ratio? Roivant Sciences (NASDAQ:ROIV) has a trailing price-to-earnings ratio of 2.09. What is Roivant Sciences's EPS forecast for next year? Roivant Sciences's earnings are expected to grow from ($1.36) per share to ($1.35) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ImmunoGen Earnings RayzeBio Earnings Crinetics Pharmaceuticals Earnings Bio-Rad Laboratories Earnings Qiagen Earnings Ascendis Pharma A/S Earnings Legend Biotech Earnings Penumbra Earnings Henry Schein Earnings Repligen Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:ROIV) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
